文献速递妇科产科

女性乳腺癌与妇科癌症的全球负担、趋势及跨国不平等:一项基于人群的研究

The global burden, trends and cross-country inequalities of female breast and gynaecologic cancers: A population based study.
PubMed 文献 · BJOG · 2024-08-05

该研究基于全球疾病负担研究2019年数据,分析女性乳腺癌与妇科癌症的年龄标化死亡率与伤残调整寿命年率、1990至2019年趋势及跨国社会不平等。结果显示全球负担总体呈下降趋势,高社会人口指数国家乳腺癌、卵巢癌和子宫癌的伤残调整寿命年负担更高,低社会人口指数国家宫颈癌负担更重,且不平等随时间加剧。

要点

  • 2019年每10万名女性的年龄标化伤残调整寿命年率:乳腺癌473.83,宫颈癌210.64,卵巢癌124.68,子宫癌210.64。
  • 1990至2019年年龄标化伤残调整寿命年率年均变化百分比均为负值,乳腺癌-0.51、宫颈癌-0.95、卵巢癌-0.08、子宫癌-0.84。
  • 高社会人口指数国家乳腺癌、卵巢癌和子宫癌伤残调整寿命年负担更高,低社会人口指数国家宫颈癌负担更重,不平等随时间增加。

核心结论

  • 1990至2019年全球女性乳腺癌与妇科癌症负担呈下降趋势,但跨国不平等随时间增加。
  • 高社会人口指数国家乳腺癌、卵巢癌和子宫癌的伤残调整寿命年负担更高,低社会人口指数国家宫颈癌负担更重。

研究设计与样本

  • 基于人群的研究,数据来源于全球疾病负担研究2019年。
  • 研究对象为确诊女性乳腺癌与妇科癌症的个体。
  • 采用年龄标化死亡率、年龄标化伤残调整寿命年率及其95%不确定区间描述负担,采用估计年度百分比变化及其置信区间描述趋势,采用斜率不平等指数和集中指数量化社会不平等。

主要发现

  • 2019年每10万名女性的年龄标化伤残调整寿命年率:乳腺癌473.83(95%不确定区间:437.30-510.51),宫颈癌210.64(95%不确定区间:177.67-234.85),卵巢癌124.68(95%不确定区间:109.13-138.67),子宫癌210.64(95%不确定区间:177.67-234.85)(原文此处子宫癌与宫颈癌数值相同,原文此处表述存在矛盾)。
  • 1990至2019年年龄标化伤残调整寿命年率的估计年度百分比变化:乳腺癌-0.51(95%置信区间:-0.57至-0.45),宫颈癌-0.95(95%置信区间:-0.99至-0.89),卵巢癌-0.08(95%置信区间:-0.12至-0.04),子宫癌-0.84(95%置信区间:-0.93至-0.75)。
  • 1990至2019年社会不平等分析中,斜率不平等指数乳腺癌从689.26变为607.08,宫颈癌从-226.66变为-239.92,卵巢癌从222.45变为228.83,子宫癌从74.61变为103.58。
  • 集中指数值范围为0.2至0.4。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyse the global burden, trends and cross-country inequalities of female breast and gynaecologic cancers (FeBGCs). DESIGN: Population-Based Study. SETTING: Data sourced from the Global Burden of Disease Study 2019. POPULATION: Individuals diagnosed with FeBGCs. METHODS: Age-standardised mortality rates (ASMRs), age-standardised Disability-Adjusted Life Years (DALYs) rates (ASDRs) and their 95% uncertainty interval (UI) described the burden. Estimated annual percentage changes (EAPCs) and their confidence interval (CI) of age-standardised rates (ASRs) illustrated trends. Social inequalities were quantified using the Slope Index of Inequality (SII) and Concentration Index. MAIN OUTCOME MEASURES: The main outcome measures were the burden of FeBGCs and the trends in its inequalities over time. RESULTS: In 2019, the ASDRs per 100 000 females were as follows: breast cancer: 473.83 (95% UI: 437.30-510.51), cervical cancer: 210.64 (95% UI: 177.67-234.85), ovarian cancer: 124.68 (95% UI: 109.13-138.67) and uterine cancer: 210.64 (95% UI: 177.67-234.85). The trends per year from 1990 to 2019 were expressed as EAPCs of ASDRs and these: for Breast cancer: -0.51 (95% CI: -0.57 to -0.45); Cervical cancer: -0.95 (95% CI: -0.99 to -0.89); Ovarian cancer: -0.08 (95% CI: -0.12 to -0.04); and Uterine cancer: -0.84 (95% CI: -0.93 to -0.75). In the Social Inequalities Analysis (1990-2019) the SII changed from 689.26 to 607.08 for Breast, from -226.66 to -239.92 for cervical, from 222.45 to 228.83 for ovarian and from 74.61 to 103.58 for uterine cancer. The concentration index values ranged from 0.2 to 0.4. CONCLUSIONS: The burden of FeBGCs worldwide showed a downward trend from 1990 to 2019. Countries or regions with higher Socio-demographic Index (SDI) bear a higher DALYs burden of breast, ovarian and uterine cancers, while those with lower SDI bear a heavier burden of cervical cancer. These inequalities increased over time.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Cheng L, Wang Z, Li R, et al. The global burden, trends and cross-country inequalities of female breast and gynaecologic cancers: A population based study. BJOG. 2024. PMID: 39099410. doi:10.1111/1471-0528.17925

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。